Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
57.33
-1.42 (-2.42%)
At close: Aug 1, 2025, 4:00 PM
56.56
-0.77 (-1.34%)
After-hours: Aug 1, 2025, 7:54 PM EDT

Company Description

Doximity, Inc. operates as a digital platform for medical professionals in the United States.

Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits.

The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems.

The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010.

Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Doximity, Inc.
Doximity logo
CountryUnited States
Founded2010
IPO DateJun 24, 2021
IndustryHealth Information Services
SectorHealthcare
Employees830
CEOJeffrey Tangney

Contact Details

Address:
500 3rd Street, Suite 510
San Francisco, California 94107
United States
Phone650 549 4330
Websitedoximity.com

Stock Details

Ticker SymbolDOCS
ExchangeNYSE
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearApril - March
Reporting CurrencyUSD
IPO Price$26.00
CIK Code0001516513
CUSIP Number26622P107
ISIN NumberUS26622P1075
Employer ID27-2485512
SIC Code7371

Key Executives

NamePosition
Jeffrey A. TangneyCo-Founder, Chief Executive Officer and Chairperson
Dr. Nathan Gross M.D.Advisor and Co-Founder
Anna BrysonChief Financial Officer
Jennifer W. Chaloemtiarana J.D.General Counsel and Corporate Secretary
Shari BuckCo-founder and SVice President People and Ops
Jey BalachandranChief Technology Officer
Perry Scott GoldHead of Investor Relations
Bruno MirandaSenior Vice President of Engineering
Joel DavisSenior Vice President of Product
Ben GreenbergSenior Vice President and GM Commercial Products

Latest SEC Filings

DateTypeTitle
Aug 1, 2025144Filing
Jul 16, 2025ARSFiling
Jul 16, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Jul 16, 2025DEF 14AOther definitive proxy statements
Jul 11, 2025144Filing
Jul 1, 2025144Filing
Jun 25, 2025144Filing
Jun 25, 2025144Filing
Jun 13, 20258-KCurrent Report
Jun 2, 2025144Filing